In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32 P-nHA Nanoparticles in Prostate Cancer Therapy.

Hao DengYumei WangYue ZhouDongliang ZhaiJie ChenShilei HaoXiaoliang Chen

Published in: International journal of nanomedicine (2023)

Tc, and DOX may be a new diagnostic and therapeutic strategy for targeting PSMA-positive prostate cancer tumors, which may achieve better therapeutic results while circumventing the severe toxic side effects of conventional chemotherapeutic agents.

Keyphrases

cancer therapy
prostate cancer
drug delivery
radical prostatectomy
pet ct
pet imaging
early onset
computed tomography
benign prostatic hyperplasia